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Abstract
Background: Eating disorders (ED) are chronic psychiatric disorders, common amongst women of reproductive
age. ED in pregnancy are associated with poor nutrition and abnormal intrauterine growth. Increasing evidence
also shows offspring of women with ED have adverse developmental and birth outcomes. We sought to carry out
the first study investigating DNA methylation in offspring of women with ED. We compared cord blood DNA
methylation in offspring of women with active ED (n = 21), past ED (n = 43) and age- and social class-matched
controls (n = 126) as part of the Avon Longitudinal Study of Parents and Children.
Results: Offspring of women with both active and past ED had lower whole-genome methylation compared to controls
(active ED 49.1% (95% confidence intervals 50.5–47.7%), past ED 49.2% (95% CI 50.7–47.7.0%), controls 52.4%
(95% CI 53.0%–51.0%)). Amongst offspring of ED women, those born to women with restrictive-type and purging-type
ED had lower methylation levels compared to those of controls. Offspring of women with an active restrictive ED
in pregnancy had lower whole-genome methylation compared to offspring of women with past restrictive ED.
We observed decreased methylation at the DHCR24 locus in offspring of women with active pregnancy ED (effect
size (ES) = − 0.124, p = 6.94 × 10−8) and increased methylation at the LGALS2 locus in offspring of women with
past ED (ES = 0.07, p = 3.74 × 10−7) compared to controls.
Conclusions: Maternal active and past ED are associated with differences in offspring whole-genome methylation. Our
results show altered DNA methylation in loci relevant to metabolism; these might be biomarkers of disrupted metabolic
pathways in offspring of ED mothers. Further work is needed to examine potential mechanisms and functional outcomes
of the observed methylation patterns.
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Background
Eating disorders (ED; anorexia nervosa, bulimia nervosa,
binge eating disorder, and other specified feeding and
eating disorders) are severe psychiatric disorders that
affect about 10% of women of reproductive age [1–3].
Maternal ED, both active—during pregnancy—and past,
have been shown to affect child eating, growth, psycho-
pathology and development [4–8]. However, little is
known about biological risk mechanisms [9]. Women
with active and lifetime ED differ from non-ED women
in terms of their food intake during pregnancy, with differ-
ences highlighted in micronutrient and macronutrient
intakes [10, 11]. Nutrient intake in pregnancy is affected
by ED type, with differences in diet composition seen in
women with anorexia nervosa (AN) compared to bulimia
nervosa (BN) and binge eating disorder (BED) [10, 11].
Maternal food intake in utero, in terms of quality and
quantity, is likely an important environmental determinant
affecting foetal metabolic adaptation to the prevailing
environmental conditions, as shown by studies on maternal
nutritional deprivation as a result of widespread famine
[12, 13]. Increasing evidence has highlighted the effect
of maternal nutrition in pregnancy on epigenetic modifica-
tions, in particular DNA methylation, both in animals and
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humans [14, 15]. Low micronutrient (methyl donors)
and protein intake, as well as low maternal pre-pregnancy
BMI, have been prospectively associated with lower glo-
bal methylation levels and hypomethylation at specific
sites [14, 16].
No studies to date have investigated the effect of
maternal ED on offspring cord blood methylation. Given
that nutrition in pregnancy is likely to differ in women
with ED compared to healthy women, our first aim was
to carry out an epigenome-wide association study (EWAS)
in offspring of mothers with ED and offspring of non-ED
mothers. There is evidence that maternal nutrition might
affect offspring methylation not just in utero but also pre-
conception [15]; we therefore also aimed to disentangle
the effect of active ED in pregnancy vs. ED at any point
prior to pregnancy, by investigating both global methyla-
tion levels and methylation at CpG sites in offspring of
women with active ED and past ED and offspring of age-
and social class-matched controls. Lastly given that ED
differ in terms of manifestation of specific behaviours, we
explored the effect of maternal restrictive eating, purging
(self-induced vomiting and laxative use for weight control)
and binge eating on overall offspring methylation.
Methods
Sample
The Avon Longitudinal Study of Parents and Children
(ALSPAC) is a longitudinal, population-based, extensive
prospective study of women and their children, set up in
the 1990s to investigate the effects of environment,
genetic and other factors on child health and develop-
ment [17, 18]. All pregnant women living in the geo-
graphical area of Avon, UK, who were expected to
deliver their baby between 1 April 1991 and 31 December
1992 were invited to take part in the study. Uptake was
high and those enrolled represented approximately 85% of
the eligible population. ALSPAC recruited 14,541 preg-
nant women; all women gave informed and written con-
sent. The study website contains details of all the data that
is available through a fully searchable data dictionary:
http://www.bris.ac.uk/alspac/researchers/data-access/data-
dictionary/. Data are accessible to all bona fide researchers
via the ALSPAC study. However, ALSPAC is required by
its ethical approvals to manage access through an applica-
tion process (which applied equally to the authors of this
manuscript).
We selected women whose offspring had available DNA
methylation data from cord blood (n = 1018) as part of the
Accessible Resource for Integrated Epigenomic Studies
(ARIES; for details, see http://www.ariesepigenomics.or
g.uk/), a representative sub-set of ALSPAC [18–20].
Offspring were not excluded from the study based on
gestational age, prematurity, low birth weight and non-
singleton pregnancies.
Exposure (maternal ED)
Amongst women with offspring methylation data from
cord blood (n = 1018), maternal active ED was determined
via three sources: (a) questionnaires at 12 weeks enquiring
about having had a recent ED; (b) questionnaires at 18 and
32 weeks in pregnancy on ED behaviours and cognitions
[including specific questions about loss of control eating,
purging (self-induced vomiting or laxative use for weight
loss) and the weight and shape concern subscales of the
Eating Disorder Examination Questionnaire (EDE-q), a
well-validated instrument [21], as previously described in
[21, 22]; and (c) validated semi-structured interviews re-
cently carried out as part of a two-phase lifetime ED preva-
lence study [3].
Women were defined as having had an active ED in
pregnancy (n = 21) if they (a) reported having had an ac-
tive ED in pregnancy (AN or BN) (n = 11) or (b) reported
symptoms consistent with an ED in pregnancy (loss of
control eating, purging, high weight and shape concern in
the context of underweight (n = 10)); or (c) reported
symptoms consistent with an ED diagnosis in pregnancy
on interviews (n = 7) (see Table 1). The majority (52.4%)
of women were categorised as having active ED in preg-
nancy based on two out of three of the above sources.
Women who self-reported having suffered from an ED
prior to pregnancy, had no ED symptoms in pregnancy,
and did not report any symptoms consistent with an ED
in pregnancy were categorised as having suffered from a
past ED (n = 43).
We also categorised women according to broad ED
diagnostic type (restrictive, purging, binge eating, binge-
purge) according to symptoms reported during and prior
to pregnancy. Amongst women with active ED, 14
(66.7%) had a restrictive ED, 3 (14.3%) a binge-purge-
type ED, 3 (14.3%) a purge-type ED and 1 (4.8%) a binge
eating ED. Amongst women with past ED, 25 had a
restrictive-type ED (58.1%), 10 (23.3%) a binge-purge-
type ED and 4 (9.3%) a purge-type ED.
Two age- and social class-matched controls were se-
lected for each case (n = 126).
Socio-demographic data
Socio-demographic (maternal social class, maternal age)
data, smoking in pregnancy, and weight and height pre-
pregnancy were obtained by self-completion questionnaire
at 12, 18 and 32 weeks’ gestation; body mass index (BMI)
was calculated as pre-pregnant weight/height2. Total energy
intake was collected via food frequency questionnaire
(FFQ), completed by the women at 32 weeks’ gestation
[10]. Offspring gender was obtained from obstetric records.
Methylation measurements and quality control
DNA was extracted and was bisulfite converted using the
Zymo EZ DNA MethylationTM kit (Zymo, Irvine, CA).
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After the conversion, DNA methylation level was mea-
sured using the Illumina Infinium® HumanMethyla-
tion450k BeadChip in line with standard protocols at the
University of Bristol, UK.
The arrays were scanned using an Illumina iScan, and
initial quality review was assessed using GenomeStudio
(version 2011.1). Further quality checks included CpG
detection p value test which removed the samples whose
average detection p value is > 0.01. We also used several
study specific variables and created multidimensional
scaling (MDS) plots to identify any potential outliers,
but all samples were within the thresholds. The measures
of DNA methylation were computed as betas (β-value)
using the minfi package in the R statistical programming
language [23]. Methylation beta values range from 0 (no
cytosine methylation) to 1 (completely cytosine methyl-
ated). Raw beta values were normalised using the functional
normalisation method of the minfi package [24]. We ex-
cluded SNPs, probes with a detection p value > 0.05 in
more than 5% samples and features on sex chromosomes.
After excluding these features, 468,782 probes were left for
analysis.
Statistical analyses
We used multiple linear regression models to explore the
effect of maternal ED on offspring cord blood methylation
using the CpGassoc R package [25].
Firstly, cord blood in offspring of mothers with active
ED, past ED and controls were compared. We profiled
overall methylation levels amongst these three groups.
We calculated a median beta value for each individual
and then computed a median beta for each exposure
group for comparisons. Crude and adjusted analyses
were performed. Adjusted analyses included bisulfite
conversion batch (BCD) to adjust for batch effects, and
principal components (computed using principal compo-
nent analysis (PCA) [26–28]. PCA was carried out to ad-
just for any unknown batch effects. Only those principal
components (PC) were included which captured most
of the variance and were not associated with the expos-
ure. Maternal smoking status and child gender were
included in all adjusted analyses as covariates. These
covariates were used as fixed effect to minimise the
computational burden.
Cell-type correction was applied using the reference-based
Houseman method [29] in the minfi package in R. This
method estimates the relative proportions of six white blood
cell subtypes (CD4+ T lymphocytes, CD8+ T lymphocytes,
NK (natural killer) cells, B lymphocytes, monocytes and
granulocytes), based on a standard reference population
[30]. Effect sizes and % methylation are reported.
We analysed four linear regression models including
model 1: a crude regression of offspring DNA methylation
on maternal ED group (as a predictor); model 2: as model
1 with adjustment for BCD and first six PCs (batches);
model 3: as model 2 with additional adjustment for covari-
ates (smoking and child gender); and model 4: as model 3
with additional adjustment for cell counts. We show re-
sults of Model 4, the fully adjusted model, throughout the
paper. In EWAS results, we highlighted cross-hybridising
probes as these probes can interfere with accurate detec-
tion of methylation levels [31].
For EWAS analyses, we computed the genomic inflation
factor and generated quantile-quantile (QQ), Manhattan
and volcano plots to compare the genome-wide distribu-
tion of p values and effect sizes across different analyses.
Methylation of two CpGs sites (uncorrected p value
< 10−7) identified in fully adjusted EWAS analysis of
active ED versus controls was profiled in the three
exposure groups: controls, active ED, and past ED.
In order to determine whether any effects of active ED
might be due to maternal underweight, we carried out
sensitivity analyses to compare our top hits with those
found in cord blood of offspring of underweight mothers
in ALSPAC [16] and in a meta-analysis of sustained
maternal smoking during pregnancy and cord blood
methylation [32].
Linear regression analyses were performed to inves-
tigate the effects of specific ED type on offspring cord
blood methylation after removing cross-hybridising
probes (n = 440,643).
Post-hoc analyses investigated whether cord blood
methylation differed in offspring of women with active
vs. past restrictive-type ED.
Results
Overall, 189 women (n = 21 with active ED, n = 43 with
past ED, n = 125 healthy controls) had data on exposure,
Table 1 Sample characteristics
Active ED (n = 21) Past ED (n = 43) Controls (n = 126)
Age, mean (SD) 26.4 (5.9) 29.1 (5.2) 28.4 (5.3)
BMI pre-pregnancy, mean (SD) 20.2 (4.4) 21.4 (2.5) 23.1 (3.9)
Smoking in pregnancy, n (%) 12 (57.1%) 9 (20.9%) 20 (15.9%)a
Child gender (female), n (%) 12 (57.1%) 22 (51.2%) 69 (54.8%)
Energy intake (kJ/day), mean (SD) 6769 (1969) 6714 (2239) 7474 (1950)
aOne subject had missing data on smoking status
Kazmi et al. Clinical Epigenetics  (2017) 9:120 Page 3 of 8
outcomes and relevant confounders under study. One
healthy control was dropped from the study sample due
to missing data on smoking in pregnancy.
Socio-demographic characteristics of the women under
study are shown in Table 1. Women with current and past
ED had lower average daily energy intake compared to
controls (F = 2.8, p = 0.06). The majority of women in the
active and past ED group had a restrictive-type ED.
Whole-genome methylation
We removed cross-hybridising probes and calculated me-
dians in order to plot and compare the overall methylation
levels across the three groups (controls, active ED and
past ED) (Additional file 1: Figure S1). Cord blood of off-
spring of women with active ED had the lowest methyla-
tion level (49.1%; 95% confidence intervals 50.5–47.7%);
offspring of controls had the highest global methylation
levels (52.4%; 95% CI 53.0–51.0%). The offspring of
women with past ED had a lower global methylation level
compared to those of controls (49.2%; 95% CI 50.7–
47.7.0%) and slightly higher than the active ED group. An
ANOVA showed medians were statistically different
across groups (p = 0.008).
Identification of differentially methylated CpGs
We carried out EWAS analyses to identify the associ-
ation between maternal eating disorder and epigenome-
wide DNA methylation in offspring cord blood mea-
sured using the Illumina HumanMethylation450 Bead-
chip. After adjustment for potential confounders and
estimated white cell counts, differences were shown in
two CpG sites between offspring of women with active
ED and controls (all p < 10−7) (seeTable 2) (Additional file 1:
Figure S2 shows the relevant QQ and Manhattan plot), and
in two CpGs between offspring of women with past ED
and controls (all p < 10−6) (see Table 2). The top two CpGs
identified in analysis of active ED and controls also passed
Bonferroni correction (1.06 × 10−7 corrected for 468,782
associations). No significantly different CpGs were identi-
fied in offspring of mothers with active vs. past ED.
In particular, offspring of women with active ED had a
hypomethylated region in cg10177197, mapping to the
DHCR24 gene, which corresponds to the gene encoding
3-β-hydroxysterol delta-24 reductase, an enzyme that
catalyses the last step in the biosynthesis of cholesterol
(also known as seladin 1). The second CpG site identi-
fied was cg21146184 on chromosome 22, which is near
the ATXN10 gene (the gene encoding Ataxin 10—a pro-
tein that may be involved in neuron survival, neuron dif-
ferentiation and neuritogenesis) [32].
Two loci were differentially methylated in offspring of
women with past ED vs. controls, and these trended for
significance following Bonferroni correction: cg05963962,
corresponding to LOC84856 (LINC00839 a long intergenic
non-protein coding element) on chromosome 10, and
cg11081833, corresponding to a soluble beta-galactoside
binding lectin (LGALS2) gene. This gene and its polymor-
phisms have been implicated in the metabolic syndrome
[33], inflammation and immune response. Additional file 1:
Figure S3 and Figure S4 shows methylation levels across
groups in these CpGs.
In order to determine whether weight status partially
explained our findings, we compared our EWAS top
CpG sites (p value < 10−4) with results from a recent
ALSPAC study on the effects of maternal over- and
underweight and offspring cord blood methylation [16].
We considered the fully adjusted model reported in [16]
in relation to maternal pre-pregnancy BMI (n = 284,972
probes) to compare the CpG sites identified in our ana-
lysis of active ED versus controls, and our top two hits
were not present in [16]. The direction of effect was not
consistent for the majority of the sites, the previously re-
ported effect sizes were smaller, and p values were larger
ranging from 0.01 to 0.99 (Additional file 2: Table S1).
We also compared the CpG sites identified in our study
in offspring of past ED versus controls with CPGs iden-
tified in [16], and the top CpG sites in our study were
not found in the previously reported study [16]. In
agreement with the previous comparison, the effect sizes
in [16] were smaller and p values were larger ranging
from 0.07 to 0.9 (Additional file 2: Table S2).
We compared the CpG sites identified in fully adjusted
EWAS of active ED versus controls (p value < 10−4) with
FDR significant sites found in a study of sustained ma-
ternal smoking in pregnancy (n = 6074 probes), and our
top two hits were not present in [32]. There were only
three overlapping CpGs (Additional file 2: Table S3). We
also compared the CpG sites identified in our study in
Table 2 Differentially methylated CpG sites in women with active ED (n = 21) and past ED (n = 43) and controls (n = 125)
CpG Chromosome Gene Effect size SE P value Bonferroni corrected Cross-hybridising Probes
Active ED vs. controls
cg21146184 22 near ATXN10 0.055 0.008448 1.60 × 10−8 0.007 No
cg10177197 1 DHCR24 −0.124 0.020012 6.94 × 10−8 0.032 No
Past ED vs. controls
cg05963962 10 LOC84856 0.08165 0.01462 3.57 × 10−7 0.16 Yes
cg11081833 22 LGALS2 0.070354 0.012624 3.74 × 10−7 0.17 No
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offspring of past ED versus controls with CPGs identi-
fied in [32] and four CpGs overlapped that include our
second top site (Additional file 2: Table S4).
We investigated the association between ED diagnostic
type (restrictive ED, purging ED, and binge eating and pur-
ging ED)—across active and past ED—and whole-genome
methylation (results are shown in Table 3). In adjusted ana-
lyses, all ED diagnostic types predicted lower offspring cord
blood methylation levels compared to controls: restrictive-
type ED (ß = − 0.011, p = 0.15), purging-type ED (ß = −
0.026, p = 0.08), and binge + purge-type ED (− 0.009,
p = 0.4) (see Table 3). Results were comparable when cross-
hybridising probes were removed.
Post-hoc analyses
As the restrictive ED group was the largest, we were
able to also explore differences in whole-genome methyla-
tion amongst women with active restrictive-type ED and
past restrictive-type ED. Offspring of women with active
restrictive-type ED had significantly lower average whole-
genome methylation (ß = − 0.07 (95% CI: − 0.069, −
0.077), p = 0.01) compared to women with past
restrictive-type ED in adjusted analyses.
Discussion
This is the first study to investigate cord blood methyla-
tion in offspring born to mothers with eating disorders.
As such, it provides novel and unique preliminary evi-
dence of likely effects of maternal ED on global methyla-
tion and specific methylation signatures in domains
relevant to metabolism and neuronal development. This
study builds not only on existing evidence on effects of
maternal ED on child development but also on novel
findings highlighting the importance of genes relevant to
metabolism in risk for ED [34, 35], and the first locus to
be identified as being significantly associated with AN at
genome-wide level [36].
Maternal eating disorders are associated with negative
developmental outcomes across a range of behavioural
and physical aspects. Pregnant women with active eating
disorders also differ from healthy women in terms of
their eating, diet and nutritional intakes and stress/anxiety
levels [10, 11, 37–39]. Hence, we hypothesised that mater-
nal eating disorders, especially if active during pregnancy,
would be associated with differential methylation patterns
in offspring cord blood. Offspring of mothers with active
ED had in fact lower global methylation, by 3.3%, compared
to offspring of age- and socio-demographic status-matched
non-ED women. Interestingly, offspring of women with
past ED had global methylation levels slightly higher
than offspring of women with active ED, but nevertheless
3% lower than offspring of non-ED women. Children of
women with restrictive-type ED and purge-type ED had
the largest differences in global methylation compared to
controls, although the number of women with purging
behaviours only was small. In line with results indicating
active pregnancy ED was associated with lowest global
methylation levels, exploratory analyses indicated that re-
strictive eating in pregnancy was associated with lower
offspring cord blood methylation compared to restrictive
eating prior to pregnancy. We also identified intriguing
significant differentially methylated CpGs in regions/genes
relevant to metabolism, and neuronal development were
associated with both maternal active and past ED.
Maternal diet and nutritional intake are amongst the
major factors influencing the developing foetus [40].
Methylation depends on the availability of methyl group do-
nors, mostly derived from diet. Therefore, hypomethylation
has been shown to ensue diets with multiple methyl-related
compounds nutrient deficiencies [41]. Epigenetic mecha-
nisms have been suggested as potential mediating factors
between maternal exposures (under and over-nutrition) and
offspring adiposity. Evidence from the ALSPAC study also
suggests that cord blood global hypomethylation is associ-
ated with maternal underweight and that hypomethylated
sites [associated with maternal underweight] were negatively
associated with offspring adiposity in later life. This suggests
a possible mechanism for intergenerational foetal program-
ming. Given the overlap between underweight and some ED
(particularly restrictive ones), the fact that our top hypo-
methylated sites were not present amongst those associated
with maternal underweight in ALSPAC strengthens our hy-
potheses that the effects seen in our study might not simply
be secondary to maternal underweight. Cord blood hypome-
thylation has also been shown as a result of maternal preg-
nancy smoking [42] in humans. Although women with ED
have higher prevalence of smoking in pregnancy [7, 22],
smoking was adjusted for in all analyses. Corroboration that
the effect of maternal ED on cord blood methylation might
be driven by eating behaviours or their epiphenomena comes
from our findings on ED-type showing lower methylation
levels in offspring of mothers with restrictive- and purge-
type ED (and within the restrictive ED subgroup, those
women who had restrictive ED in pregnancy).
Table 3 Whole-genome cord blood methylation levels in
offspring of women across ED types and controls: adjusted
linear regression
ED type ß (SE) p value R2, p value
Restrictive ED (n = 39) − 0.011 (0.008) 0.15 0.84, 2.7 × 10−15
Binge purge ED (n = 13) − 0.009 (0.012) 0.42
Purging ED (n = 7) − 0.026 (0.015) 0.08
Covariates:
Smoking 0.01 (0.007) 0.14
Gender − 0.002 (0.006) 0.67
Adjusted for maternal smoking in pregnancy, child gender, cell count and
bisulfite conversion batch
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Cord blood methylation has also been suggested as a
potential biomarker of altered child neurodevelopment
[43], and research linking specific gene methylation and
child neurodevelopmental outcomes has shown promis-
ing results. Our study highlights interesting differences
in differentially methylated CpGs between offspring of
ED mothers and controls. In particular, we identified
differential methylation in genes relevant to lipid syn-
thesis (DHCR24, LGALS2) [44]. DHCR24 is responsive
to lipid levels [45] and oestrogen [44], both likely to be
abnormal in active ED and therefore possibly relevant
to foetal programming. In fact, there is evidence that
expression of DHCR24 is relevant to foetal programming.
DHCR24 hepatic transcription is differentially induced by
maternal undernutrition and low-protein diet in rats [46]
and mice [47]; expression of DHCR24 and related genes in
the placenta was associated with foetal growth [48]. Two
differentially methylated CpGs identified were in and near
genes relevant to general pathways of normal embryonic
and placental development (LGALS2) and neurogenesis
(ATXN10). These findings provide initial preliminary in-
sights into possible biological effects of maternal ED; map-
ping onto existing evidence of both (a) developmental
effects of maternal ED [4] and (b) risk pathways likely to
be relevant to the intergenerational cycle of risk of ED [9].
Our findings have to be interpreted in the context of
strengths and limitations. This is the first study to investi-
gate methylation in offspring of women with ED. ED were
ascertained using a triangulation method relying on self-
report and interviews; we were able to test the effect of
active ED vs. past ED. Given the nature of the sample, we
were able to match controls to cases and adjust for con-
founders known to affect methylation levels, e.g. smoking.
This study, however, is limited by the relatively small sam-
ple size, which nevertheless allowed exploration of the ef-
fect of ED type on the outcome. Other limitations include
that no technical validation (e.g. pyrosequencing) was per-
formed; studies have shown that the Illumina microarrays
are less sensitive to extreme methylation levels [49, 50].
Conclusions
This study provides for the first time evidence of the
effect of maternal ED on early biological markers of off-
spring development, i.e. cord blood methylation. We
showed important effects on genome-wide methylation
levels and methylation of specific genes relevant to me-
tabolism. Replication of our findings will be important.
Recent studies have shown persistence of methylation
levels into childhood [51]; hence, understanding whether
differences identified in methylation are persistent and
whether they are associated with adverse developmental
outcomes will allow a more in-depth understanding of
developmental risk pathways relevant to the intergenera-
tional transmission of ED and broader psychopathology.
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